Whittaker M, Wicks R J, Britten J J
Clin Chim Acta. 1982 Feb 26;119(1-2):107-14. doi: 10.1016/0009-8981(82)90410-7.
Human erythrocyte acetylcholinesterase and the plasma cholinesterase variants are not only inhibited by propranolol but have been found to show stereospecificity for its isomers. The erythrocyte enzyme has a greater affinity for the L-isomer than either the racemate or the D-isomer. In contrast the plasma cholinesterases have greater specificity for the D-isomer than the other isomer or racemate. The usual enzyme shows greater stereospecificity than the atypical enzyme and these findings present additional evidence that these enzyme variants differ in structure at the catalytic active site. Neither Na+ + K+ -ATPase nor Mg2+-ATPase show stereo-specificity for the isomers of propranolol although both enzymes are inhibited by the drug. The action of the drug on the four enzymes in blood samples obtained from patients having Huntington's disease was found to be identical to those observed on the enzymes in blood samples from healthy controls.
人红细胞乙酰胆碱酯酶和血浆胆碱酯酶变体不仅会被普萘洛尔抑制,而且已发现其对普萘洛尔的异构体具有立体特异性。红细胞酶对L-异构体的亲和力大于外消旋体或D-异构体。相比之下,血浆胆碱酯酶对D-异构体的特异性高于其他异构体或外消旋体。正常酶比非典型酶表现出更高的立体特异性,这些发现进一步证明了这些酶变体在催化活性位点的结构上存在差异。尽管这两种酶都被该药物抑制,但钠钾ATP酶和镁ATP酶对普萘洛尔的异构体均无立体特异性。研究发现,该药物对亨廷顿舞蹈症患者血液样本中这四种酶的作用,与在健康对照者血液样本中观察到的对这些酶的作用相同。